Induction Yervoy (ipilimumab) plus Opdivo (nivolumab) followed by consolidative chemoradiotherapy demonstrated bladder ...

A 79-year-old man may have been in a state of paranoia or confusion from cancer treatment or his impending death when police say he attacked his wife with a knife and hammer last month in ...

To further complicate clinicians’ treatment decisions, Padcev-Keytruda has become the new standard of care in first-line metastatic bladder cancer, raising the possibility that some physicians might ...

More than 5000 Australians struggling with rare and advanced cancers will be able to access two new immunotherapy drugs for ...

Amgen reported progress across its KRAS inhibitor portfolio, including Lumakras and next generation candidates such as AMG ...

A 79-year-old man may have been in a state of paranoia or confusion from cancer treatment or his impending death when police say he attacked his wife with a knife ...

Leerink Global Healthcare Conference 2026 March 11, 2026 9:20 AM EDTCompany ParticipantsJasper Van GrunsvenPeter Griffith - Executive ...

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar ...

The price for the same prescription drug in different hospitals nationwide could have more than a $10,000 difference, according to a new report. A report from 3 Axis Advisors used publicly available ...

The price for the same prescription drug in different hospitals nationwide could have more than a $10,000 difference, according to a new report.

From today, thousands more Australians living with advanced and rare cancers will have access to affordable immunotherapy treatment options through ...

Antonio Ocejo, MD, discussed a multi-institutional analysis focusing on the clinical outcomes and tolerability of ipilimumab ...